Kronox Lab Sciences Recommends ₹0.50 Dividend, Approves Audited Results for FY26
Kronox Lab Sciences approved audited standalone results for the quarter and year ended March 31, 2026. The Board recommended a dividend of ₹0.50 per share. Total income for FY26 was ₹10,641.40 Lakhs, and profit after tax was ₹2,766.00 Lakhs. The earnings per share (EPS) for the year is ₹7.51.
The dividend announcement and positive financial results are likely to have a moderate positive impact on investor sentiment.
The announcement includes positive financial results for the year ended March 31, 2026, and the recommendation of a dividend, indicating a positive outlook.
Kronox Lab Sciences Limited announced the outcomes of its Board Meeting held on May 21, 2026, including the approval of audited standalone financial results for the quarter and financial year ended March 31, 2026. The board recommended a dividend of 5% i.e. ₹0.50 per share (face value of ₹10 per equity share), subject to the approval of members. The Board Meeting commenced at 04:00 p.m. and concluded at 05:00 p.m. on May 21, 2026.
The audited financial results indicate that the total income for the year ended March 31, 2026, was ₹10,641.40 Lakhs, compared to ₹10,272.0 Lakhs in the previous year. The profit after tax for the year stood at ₹2,766.00 Lakhs, up from ₹2,545.7 Lakhs in the previous year. The earnings per share (EPS) for the year is ₹7.51, compared to ₹6.81 in the previous year.
The company's balance sheet shows total assets of ₹12,752.3 Lakhs as of March 31, 2026, compared to ₹9,882.6 Lakhs the previous year. Equity Share Capital is ₹3,710.4 Lakhs and Other Equity is ₹7,902.3 Lakhs.
What to do with a filing like this
Kronox Lab Sciences Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kronox Lab Sciences Limited. Read the original for the full detail.